1. MECHANISM OF ACTION
Mesterolone operates as an orally active, 1-methylated derivative of dihydrotestosterone (DHT), structurally configured to prevent rapid enzymatic deactivation in hepatic tissue without requiring 17-alpha-alkylation. Characterized by its strong binding affinity for sex hormone-binding globulin (SHBG), the compound successfully frees up larger percentages of circulating free hormones within the endocrine matrix. It does not convert into estrogenic metabolites via the aromatase pathway, establishing an authoritative baseline framework for regulating biological density and preserving localized physiological homeostasis.
2. THE RETAIL & KIT ARCHITECTURE
- Configuration: 100 Tablets / Box (2 x 50 tabs)
- Concentration: 20 mg per Tablet
- Formulation: Micronized Oral Matrix
3. TECHNICAL SPECIFICATIONS
| Attribute | Details |
|---|---|
| Active Compound | Mesterolone |
| Concentration Profile | 20 mg / tablet |
| Molecular Structure | C20H32O2 |
| Composition Base | Micronized Oral Tablet Matrix |
| SKU Number | ORA-ME20-100T |



-100x100.jpeg)


